BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/3/2021 11:06:30 AM | Browse: 454 | Download: 651
 |
Received |
|
2021-03-28 08:13 |
|
Peer-Review Started |
|
2021-03-28 08:23 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-04-28 21:58 |
|
Revised |
|
2021-07-03 11:51 |
|
Second Decision |
|
2021-08-24 03:20 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-08-24 09:31 |
|
Articles in Press |
|
2021-08-24 09:31 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-08-29 09:45 |
|
Publish the Manuscript Online |
|
2021-09-03 11:06 |
| ISSN |
2308-3840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Troponin I biomarker as a strong prognostic factor for predicting COVID-19 mortality: A systematic review
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Haleh Ashraf, Abbas Soleimani, Ali Kazemi saeid, Azadeh Sadat Naseri, Fazeleh Majidi, Niloufar Peirovi and Shahrokh Karbalai Saleh |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Shahrokh Karbalai Saleh, MD, Assistant Professor, Department of Cardiology, Tehran University of Medical Sciences, Imam Khomeini St. Sina Hospital, Tehran 1136746911, Iran. saleh6948@yahoo.com |
| Key Words |
Troponin-I; COVID-19; Mortality; Morbidity; Cardiac biomarker; Acute respiratory distress syndrome |
| Core Tip |
We systematically reviewed the literatures to assess this claim that an increase in troponin-I levels could be a prognostic factor in predicting disease severity and mortality in patients with coronavirus disease 2019. According to our findings, regardless of the history of myocardial injuries or the presence of cardiovascular risk profile, the value of troponin I should be accurately assessed on admission. Raising troponin-I on admission can be linked to the increase risk for in-hospital death, acute respiratory distress syndrome, kidney injury, and intensive care unit admission by 4.9, 5.9, 3.8, and 3.7 times as compared to those with initial normal troponin I concentration. |
| Publish Date |
2021-09-03 11:06 |
| Citation |
Ashraf H, Soleimani A, Kazemi saeid A, Sadat Naseri A, Majidi F, Peirovi N, Karbalai Saleh S. Troponin I biomarker as a strong prognostic factor for predicting COVID-19 mortality: A systematic review and meta-analysis. World J Meta-Anal 2021; 9(4): 342-352 |
| URL |
https://www.wjgnet.com/2308-3840/full/v9/i4/342.htm |
| DOI |
https://dx.doi.org/10.13105/wjma.v9.i4.342 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
